
News
Read the latest news from Sciad and our clients
Sciad Spotlight
Sciad Spotlight
Our guide to GA4 – new features, getting started, and useful tips & tricks
16th January 2023
Client News
Watson-Marlow to create biodiverse native woodland in Ireland
15th December 2022
Client News
NoriZite™ Nasal Spray blocks infection with Omicron SARS-CoV-2 variant in cell culture
15th December 2022
Client News
Client News
BRIM Biotechnology receives FDA Orphan Drug Designation for BRM424 to treat neurotrophic keratitis
8th December 2022
Client News
MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease
6th December 2022
Client News
Pharma and healthcare leaders discuss the innovations to fix our health system at Pharma Integrates 2022
5th December 2022
Client News
Client News
BRIM Biotechnology, Inc. raises $20 million in Series E funding round
1st December 2022
Client News
Gelomics Partners With Rousselot Biomedical to Create the World’s First, Ready-to-Use 3D Cell Culture Kits Based on X-PURE® GelMA
16th November 2022
Client News
Domainex expands Executive and Management Teams to support ongoing growth
15th November 2022
Client News
Client News
BRIM Biotechnology receives FDA agreement on Phase 3 clinical trial design for BRM421, BRIM’s lead candidate for Dry Eye Disease, at End of Phase 2 Meeting
1st November 2022
Client News
Watson-Marlow to create biodiverse native woodland in Ireland
15th December 2022
Client News
NoriZite™ Nasal Spray blocks infection with Omicron SARS-CoV-2 variant in cell culture
15th December 2022
Client News
Client News
BRIM Biotechnology receives FDA Orphan Drug Designation for BRM424 to treat neurotrophic keratitis
8th December 2022
Client News
MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease
6th December 2022
Client News
Pharma and healthcare leaders discuss the innovations to fix our health system at Pharma Integrates 2022
5th December 2022
Client News
Client News
BRIM Biotechnology, Inc. raises $20 million in Series E funding round
1st December 2022
Client News
Gelomics Partners With Rousselot Biomedical to Create the World’s First, Ready-to-Use 3D Cell Culture Kits Based on X-PURE® GelMA
16th November 2022
Client News
Domainex expands Executive and Management Teams to support ongoing growth
15th November 2022
Client News
Client News
BRIM Biotechnology receives FDA agreement on Phase 3 clinical trial design for BRM421, BRIM’s lead candidate for Dry Eye Disease, at End of Phase 2 Meeting
1st November 2022
Loading
Got an innovation you need bringing to life?
We’d love to hear from you! Head to our contact page to start a conversation.
